CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and functionDuohui Jing, Martin Bornhäuser, Uta Oelschlaegel et al.|Bone Marrow Transplantation|2010Cited by 56
Whole blood genome-wide expression profiling and network analysis suggest MELAS master regulatorsS. Mende, Alexander Storch, Marcus Deschauer et al.|Neurological Research|2011Cited by 12